Tag: Bolster

NetworkNewsWire Editorial Coverage NEW YORK, July 15, 2025 /CNW/ -- For decades, mining has been defined by high-risk, high-capex exploration, where success hinges on one-in-a-thousand...

Collaboration aims to bolster the renewable energy company's people-centred approach, elevating the employee experience and fostering operational efficiency LONDON, July 15, 2025 /PRNewswire/ -- Cognizant (Nasdaq:...

Dept. of Commerce, Sen. Schumer, Rep. Tonko, Natcast, NY CREATES, NSTC Members, and leaders from across industry and academia came together to celebrate this...

LEWISVILLE, Texas, July 14, 2025 /PRNewswire/ -- Wayne Dalton™ is introducing new hydraulic dock levelers: Models H68WD and H78WD, which were designed with durability,...

SINGAPORE, July 14, 2025 /PRNewswire/ -- BTC Digital Ltd. ("BTCT" or the "Company") (NASDAQ: BTCT), a leading blockchain technology company, today announced the formal launch...

BEIJING, July 11, 2025 /PRNewswire/ -- On a recent sunny morning in the coastal city of Xiamen in East China's Fujian Province, as temperatures surged,...

The second stop of CIEE's year-long, nationwide roadshow celebrates Xanterra and Big Sky employers as exceptional supporters of the U.S. Department of State's BridgeUSA...

The global adrenal crisis market is witnessing significant growth driven by increasing adrenal insufficiency recognition and rising adrenal crisis incidents. The expanding global prevalence of autoimmune diseases and corticosteroid use for chronic conditions further accelerates market demand. However, challenges such as high treatment costs, limited awareness in low-income regions, and diagnostic complexities may slow adoption in emerging markets. Between 2025-2035, advancements in diagnostic technologies and innovative therapies are expected to bolster market growth, though access issues remain crucial. Key players like Eton Pharmaceuticals, Antares Pharma, and Pfizer are leading with product innovation and strategic partnerships.

The global adrenal crisis market is witnessing significant growth driven by increasing adrenal insufficiency recognition and rising adrenal crisis incidents. The expanding global prevalence of autoimmune diseases and corticosteroid use for chronic conditions further accelerates market demand. However, challenges such as high treatment costs, limited awareness in low-income regions, and diagnostic complexities may slow adoption in emerging markets. Between 2025-2035, advancements in diagnostic technologies and innovative therapies are expected to bolster market growth, though access issues remain crucial. Key players like Eton Pharmaceuticals, Antares Pharma, and Pfizer are leading with product innovation and strategic partnerships.

New additions bolster Hapbee as it scales product reach, tech pipeline, and international presence.

New additions bolster Hapbee as it scales product reach, tech pipeline, and international presence.

According to DelveInsight's analysis, the Lewy body dementia market is anticipated to increase during the forecast period (2025–2034), owing to the launch of emerging...

According to DelveInsight's analysis, the Lewy body dementia market is anticipated to increase during the forecast period (2025–2034), owing to the launch of emerging...

Additionally, the companies expanded their photovoltaic module R&D collaboration focused on optimizing performance of utility-scale solar LOS ALAMOS, N.M., July 9, 2025 /PRNewswire/ -- UbiQD®, a...

Graphenix Development Inc., a Rochester-based battery materials firm, receives a $100,000 SuperBoost grant from the NSF Energy Storage Engine.

HONG KONG, July 8, 2025 /PRNewswire/ -- J&T Global Express Limited ("J&T Express" or "J&T" or "the Company", stock code: 01519), a global logistics...